DDI-DrugBank.d702.s0 >> SPIRIVA has been used concomitantly with other drugs commonly used in COPD without increases in adverse drug reactions. >> 0-6
DDI-DrugBank.d702.s1 >> These include sympathomimetic bronchodilators, methylxanthines, and oral and inhaled steroids. >> 14-44,47-61,85-92
DDI-DrugBank.d702.s2 >> However, the co   administration of SPIRIVA with other anticholinergic   containing drugs (e.g., ipratropium) has not been studied and is therefore not recommended. >> 36-42,55-69,97-107
